• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蕈样肉芽肿转化的预后因素:100 例回顾性分析。

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.

机构信息

Department of Dermatology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Blood. 2012 Feb 16;119(7):1643-9. doi: 10.1182/blood-2011-08-376319. Epub 2011 Dec 12.

DOI:10.1182/blood-2011-08-376319
PMID:22160616
Abstract

Large cell transformation (LCT) in mycosis fungoides (MF) is generally associated with an aggressive clinical course and poor survival, requiring aggressive therapeutic approach. However, a proportion of cases may follow an indolent clinical course. To identify prognostic factors, we analyzed the prognostic relevance of clinical, histologic, and immunophenotypical features in a large cohort of transformed MF patients, including 75 patients with only skin lesions, 19 patients with LCT in skin and lymph nodes, and 6 patients with LCT in lymph nodes only. Multivariate analysis of the total group showed that CD30 negativity, folliculotropic MF, extent of skin lesions and extracutaneous transformation were associated with reduced disease-specific survival (DSS) and, except for CD30 negativity and folliculotropic MF, also overall survival. In a multivariate analysis of 75 patients with only skin lesions at the time of LCT, CD30 negativity, folliculotropic MF and extent of skin lesions were independent parameters for both DSS and overall survival. Using the most discriminating parameters as a prognostic index, in both study groups differences in DSS between patients with 0-1 unfavorable prognostic factor(s) and ≥ 2 unfavorable prognostic factors were statistically significant (P < .001). This prognostic index may be helpful in predicting prognosis and selecting the most appropriate treatment in patients with transformed MF.

摘要

蕈样肉芽肿中出现大细胞转化(LCT)通常与侵袭性临床病程和较差的生存相关,需要积极的治疗方法。然而,一部分病例可能表现为惰性的临床病程。为了明确预后因素,我们分析了 75 例仅有皮肤病变、19 例皮肤和淋巴结均有 LCT、6 例仅有淋巴结受累的 LCT 患者的临床、组织学和免疫表型特征的预后相关性。总组的多变量分析显示,CD30 阴性、亲毛囊性蕈样肉芽肿、皮肤病变范围和皮肤外转化与疾病特异性生存(DSS)降低相关,除 CD30 阴性和亲毛囊性蕈样肉芽肿外,还与总生存相关。在仅有皮肤病变时出现 LCT 的 75 例患者的多变量分析中,CD30 阴性、亲毛囊性蕈样肉芽肿和皮肤病变范围是 DSS 和总生存的独立预后因素。使用最具鉴别性的参数作为预后指数,在两个研究组中,DSS 有 0-1 个不利预后因素和≥2 个不利预后因素的患者之间存在统计学差异(P<.001)。该预后指数有助于预测预后,并为 LCT 患者选择最合适的治疗方法。

相似文献

1
Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.蕈样肉芽肿转化的预后因素:100 例回顾性分析。
Blood. 2012 Feb 16;119(7):1643-9. doi: 10.1182/blood-2011-08-376319. Epub 2011 Dec 12.
2
Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.187例转化型蕈样肉芽肿预后因素的回顾性分析
Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):49-56. doi: 10.1016/j.clml.2015.11.010. Epub 2015 Dec 1.
3
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.蕈样肉芽肿和塞扎里综合征晚期皮肤淋巴瘤国际联盟预后研究:特定预后标志物对生存的影响及预后模型的建立
J Clin Oncol. 2015 Nov 10;33(32):3766-73. doi: 10.1200/JCO.2015.61.7142. Epub 2015 Oct 5.
4
Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.蕈样肉芽肿/赛泽里综合征的生存结局和预后因素:修订的国际皮肤淋巴瘤学会/欧洲癌症研究与治疗组织分期建议的验证。
J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20.
5
Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sézary syndrome in the southeastern United States: a single-institution cohort.美国东南部 393 例蕈样肉芽肿和赛泽里综合征患者的临床特征、预后因素和生存情况:单机构队列研究。
J Am Acad Dermatol. 2015 Feb;72(2):276-85. doi: 10.1016/j.jaad.2014.10.019. Epub 2014 Nov 17.
6
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.60例蕈样肉芽肿和塞扎里综合征患者淋巴结的分子分期:与组织病理学及预后的相关性提示其在蕈样肉芽肿中具有预后意义。
Br J Dermatol. 2006 Oct;155(4):756-62. doi: 10.1111/j.1365-2133.2006.07428.x.
7
[Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.[译文] 148 例皮肤 T 细胞淋巴瘤病例系列的生存分析和预后因素。
Actas Dermosifiliogr. 2024 Sep;115(8):T766-T772. doi: 10.1016/j.ad.2024.07.006. Epub 2024 Jul 6.
8
Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.非洲裔美国人和黑人蕈样肉芽肿/赛泽里综合征患者的结局和预后因素:来自转诊癌症中心的 157 例患者的回顾性分析。
J Am Acad Dermatol. 2020 Aug;83(2):430-439. doi: 10.1016/j.jaad.2019.08.073. Epub 2019 Sep 6.
9
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndrome.蕈样肉芽肿和塞扎里综合征的皮肤淋巴瘤国际预后指数(CLIPI)验证
Leuk Lymphoma. 2016 Dec;57(12):2813-2819. doi: 10.3109/10428194.2016.1173210. Epub 2016 Apr 22.
10
Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis.蕈样肉芽肿/塞扎里综合征的转化:临床特征与预后
Turk J Haematol. 2018 Mar 1;35(1):35-41. doi: 10.4274/tjh.2016.0502. Epub 2017 May 23.

引用本文的文献

1
Large-cell transformation of mycosis fungoides: Patterns of care and patient outcomes.蕈样肉芽肿的大细胞转化:治疗模式与患者预后
Br J Haematol. 2025 Sep;207(3):824-833. doi: 10.1111/bjh.20225. Epub 2025 Jun 25.
2
Condensed low-dose total skin electron beam therapy for mycosis fungoides: an institutional retrospective review and subgroup analysis of patients with large cell transformation.浓缩低剂量全身电子束疗法治疗蕈样肉芽肿:一项机构回顾性研究及大细胞转化患者的亚组分析
Arch Dermatol Res. 2025 Mar 8;317(1):531. doi: 10.1007/s00403-025-04030-3.
3
The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression.
癌症相关成纤维细胞在蕈样肉芽肿中与恶性T细胞相互作用,并促进疾病进展。
Front Immunol. 2025 Feb 3;15:1474564. doi: 10.3389/fimmu.2024.1474564. eCollection 2024.
4
Antibody-Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism.靶向T细胞淋巴瘤中CD30的抗体药物偶联物:临床进展与机制
Cancers (Basel). 2025 Feb 2;17(3):496. doi: 10.3390/cancers17030496.
5
When mycosis fungoides seems not to be within the spectrum of clinical and histopathological differential diagnoses.当蕈样肉芽肿似乎不在临床和组织病理学鉴别诊断范围内时。
Dermatol Reports. 2024 May 7;16(Suppl 2):10008. doi: 10.4081/dr.2024.10008.
6
H-1 Parvovirus-Induced Oncolysis and Tumor Microenvironment Immune Modulation in a Novel Heterotypic Spheroid Model of Cutaneous T-Cell Lymphoma.H-1细小病毒在皮肤T细胞淋巴瘤新型异型球体模型中诱导的肿瘤溶解和肿瘤微环境免疫调节
Cancers (Basel). 2024 Jul 30;16(15):2711. doi: 10.3390/cancers16152711.
7
The Prognostic Value of Histopathological Features in Early-Stage Mycosis Fungoides: Insights from a Retrospective-Prospective Cohort Study.早期蕈样肉芽肿组织病理学特征的预后价值:一项回顾性-前瞻性队列研究的见解
Dermatopathology (Basel). 2024 Jun 14;11(2):161-176. doi: 10.3390/dermatopathology11020017.
8
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma.纳武单抗联合本妥昔单抗治疗复发/难治性外周T细胞淋巴瘤和皮肤T细胞淋巴瘤。
Blood Adv. 2024 May 28;8(10):2400-2404. doi: 10.1182/bloodadvances.2023011030.
9
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.蕈样肉芽肿的基因组分析可识别具有高疾病进展风险的患者。
Blood Adv. 2024 Jun 25;8(12):3109-3119. doi: 10.1182/bloodadvances.2023012125.
10
Diffuse Large B-Cell lymphoma Misdiagnosed as a Hematoma: Case Report.弥漫性大 B 细胞淋巴瘤误诊为血肿:病例报告。
Medicina (Kaunas). 2023 Oct 5;59(10):1775. doi: 10.3390/medicina59101775.